This inventor holds 1 USPTO granted patent. Top assignee: Qingdao Haier Biotech Co., Ltd. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Qilong Cao: Innovator in Stem Cell Therapy
Introduction
Qilong Cao is a prominent inventor based in Qingdao, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments for medical conditions.
Latest Patents
One of Qilong Cao's notable patents is an eyedrop applicable to limbal stem cell deficiency. This invention includes a unique formulation that consists of 1 to 40 mg of human adipose-derived stem cell exosomes per liter. The eyedrop also contains excipients such as 0.5 to 2 g of sodium hyaluronate, 0.5 to 3 g of vitamin B6, and 0.05 to 0.3 g of benzalkonium chloride, with the balance being medical normal saline. The pH of the eyedrop is maintained between 6.5 to 7.5, making it effective in treating limbal stem cell deficiency.
Career Highlights
Qilong Cao is associated with Qingdao Haier Biotech Co., Ltd., where he continues to work on groundbreaking research and development projects. His expertise in biotechnology has led to advancements that benefit patients suffering from various medical conditions.
Collaborations
Qilong Cao collaborates with talented professionals in his field, including Hui Li and Fei Wang. Their combined efforts contribute to the innovative environment at Qingdao Haier Biotech Co., Ltd.
Conclusion
Qilong Cao is a dedicated inventor whose work in stem cell therapy is paving the way for new treatment options. His contributions to biotechnology are noteworthy and have the potential to improve the quality of life for many individuals.